February 06, 2020
Rose
Merck's rivals Pfizer and GlaxoSmithKline have made similar moves. In addition to women’s health medicines and older, off-patent brands, the new business will include the less expensive versions of branded biotech drugs. In other pharmaceutical news: a multiple sclerosis drug, patents for HIV prevention pills, recalls, biotech news and more.
from Kaiser Health News https://ift.tt/2S4ovOO
February 06, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
100 Million Covid Shots in 100 Days Doesn’t Get Us Back to Normal- Lost on the Frontline: Explore the Database
- In Austin, Some Try to Address Vaccine Inequity, but a Broad Plan Is Elusive
- Dispelling Vaccine Misinformation and Myths in California’s Breadbasket
- Cien millones de vacunas contra covid en 100 días no nos hará volver a la normalidad
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment